Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bydureon
Company Monitoring Page for Bydureon
latest headlines for company on cafepharma
FDA offers former biotech unicorn Intarcia a chance for a panel review
BioPharma Dive
Thu, 02/9/23 - 06:04 pm
Tags:
FDA
,
Intarcia
,
diabetes
,
drug-eluting
,
ITCA 650
,
Bydureon
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes
Fierce Pharma
Fri, 06/25/21 - 12:16 pm
Tags:
AstraZeneca
,
Bydureon
,
diabetes
,
pediatric
,
type 2 diabetes
,
clinical trials
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
Tags:
diabetes
,
insulin
,
Mt Sinai
,
Novo Nordisk
,
Ozempic
,
Rybelsus
,
Victoza
,
Eli Lilly
,
Trulicity
,
AstraZeneca
,
Bydureon
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
Tags:
diabetes
,
Eli Lilly
,
Merck
,
Novo Nordisk
,
GSK
,
Byetta
,
Victoza
,
Bydureon
,
Ozempic
,
Tanzeum
,
Trulicity
,
Rybelsus
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
Tue, 07/24/18 - 10:32 am
Tags:
diabetes
,
Parkinson's Disease
,
GLP-1 agonist
,
AstraZeneca
,
Byetta
,
Bydureon
,
Novo Nordisk
,
Victoza
,
Ozempic
,
Eli Lilly
,
Trulicity
,
Peptron
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
Fierce Pharma
Mon, 06/25/18 - 09:07 pm
Tags:
Eli Lilly
,
Trulicity
,
diabetes
,
Novo Nordisk
,
Victoza
,
AstraZeneca
,
Bydureon
,
ADA
AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval
Drug Delivery Business News
Tue, 04/3/18 - 10:52 pm
Tags:
AstraZeneca
,
diabetes
,
Bydureon
,
FDA
FDA clears AstraZeneca’s once-weekly Type II diabetes drug-device combo
Drug Delivery Business News
Mon, 10/23/17 - 10:01 am
Tags:
AstraZeneca
,
FDA
,
diabetes
,
drug-device combos
,
Bydureon
AstraZeneca's Bydureon fails to show cardio-protection
BioPharma Dive
Thu, 09/14/17 - 10:05 pm
Tags:
EASD
,
AstraZeneca
,
Bydureon
,
diabetes
AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?
Fierce Pharma
Tue, 05/23/17 - 08:17 am
Tags:
AstraZeneca
,
Bydureon
,
diabetes
,
Novo Nordisk
,
Victoza
Next stop in AstraZeneca fire sale: China
BioPharma Dive
Thu, 10/13/16 - 03:27 pm
Tags:
AstraZeneca
,
China
,
Byetta
,
Bydureon
AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes
Yahoo
Sun, 06/12/16 - 12:29 pm
Tags:
AstraZeneca
,
Bydureon
,
clinical trials
,
diabetes
,
type 2 diabetes
Novo's weekly diabetes drug clears another Phase III hurdle
Fierce Biotech
Fri, 09/25/15 - 08:45 pm
Tags:
Novo Nordisk
,
diabetes
,
semaglutide
,
Bydureon
,
AstraZeneca
Bydureon, Invokana, Xarelto brand teams shelled out most to doctors in 2014
Fierce Pharma Marketing
Wed, 07/8/15 - 11:34 am
Tags:
Bydureon
,
Invokana
,
Xarelto
,
physicians
,
physician payments
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
Seeking Alpha
Wed, 04/2/14 - 09:52 pm
Tags:
Bydureon
,
insulin
,
Bristol-Myers Squibb
,
diabetes
AstraZeneca announces FDA approval of Bydureon Pen
The Fly on the Wall
Mon, 03/3/14 - 10:05 am
Tags:
FDA
,
diabetes
,
AstraZeneca
,
Bydureon
,
Bydureon pen
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
Thu, 02/27/14 - 08:19 am
Tags:
FDA
,
diabetes
,
Merck
,
Januvia
,
Janumet
,
Novo Nordisk
,
Victoza
,
Bristol-Myers Squibb
,
Byetta
,
Bydureon
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:02 pm
Tags:
Victoza
,
Novo Nordisk
,
Eli Lilly
,
dulaglutide
,
diabetes
,
Bydureon
,
AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
Tags:
AstraZeneca
,
dulaglutide
,
GSK
,
Eli Lilly
,
Bydureon
,
diabetes
AstraZeneca, Bristol Recall Bydureon Diabetes Drug For Under-Filled Vials
WSJ Online
Fri, 09/20/13 - 10:20 am
Tags:
AstraZeneca
,
Bristol-Myers Squibb
,
Bydureon
,
diabetes
,
recalls
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.